Donor bone marrow infusions are tolerogenic in human renal transplantation

被引：4
|
作者：
Ciancio, G
Garcia-Morales, R
Mathew, J
Carreno, M
Burke, GW
Ricordi, C
Kenyon, N
Esquenazi, V
Cirocco, R
Tzakis, A
Miller, J
机构：
[1] Univ Miami, Sch Med, Div Transplantat, Dept Surg,Diabet Res Inst, Miami, FL 33101 USA
[2] Miami Vet Affairs Med Ctr, Miami, FL USA
来源：
TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(00)02485-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1295 / 1296
页数：2
相关论文
共 50 条
  • [41] Infusions into the bone marrow
    不详
    BRITISH MEDICAL JOURNAL, 1942, 1942 : 48 - 48
  • [42] Enhanced allograft acceptance by multiple infusions of donor bone marrow in humans
    Ricordi, C
    Karatzas, T
    Selvaggi, G
    Neri, J
    Fernandez, H
    Ruiz, MP
    Linetsky, E
    Kong, SS
    Webb, M
    Bottino, R
    Quian, T
    Ciancio, G
    Carreno, M
    Cirocco, R
    Garcia, R
    Olsen, L
    Esquinazi, V
    Miller, J
    Schiff, E
    Tzakis, AG
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3381 - 3381
  • [43] Effect of timing of donor bone marrow infusions on liver allograft survival
    Ricordi, C
    Karatzas, T
    Nery, J
    Webb, M
    Fernandez, L
    Selvaggi, G
    Garcia, R
    Goldberg, M
    Schiff, E
    Olson, L
    Ruiz, P
    Esquenazi, V
    Miller, J
    Tzakis, AG
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1186 - 1186
  • [44] Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells
    LF Verdonck
    EJ Petersen
    HM Lokhorst
    HK Nieuwenhuis
    AW Dekker
    MGJ Tilanus
    RA de Weger
    Bone Marrow Transplantation, 1998, 22 : 1057 - 1063
  • [45] Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells
    Verdonck, LF
    Petersen, EJ
    Lokhorst, HM
    Nieuwenhuis, HK
    Dekker, AW
    Tilanus, MGJ
    de Weger, RA
    BONE MARROW TRANSPLANTATION, 1998, 22 (11) : 1057 - 1063
  • [46] Tolerance Induction with Donor Bone Marrow Transplantation in Kidney Transplantation
    Park, H.
    Lee, N.
    Lee, S.
    Choi, G.
    Kwon, C.
    Kim, S.
    Joh, J. -W.
    Kim, M.
    Kwon, Y.
    Lee, S. -K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 270 - 270
  • [47] Outcomes of renal transplantation following bone marrow transplantation
    Hamawi, K
    de Magalhaes-Silverman, M
    Bertolatus, JA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (03) : 301 - 305
  • [48] Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
    Porter, DL
    Collins, RH
    Hardy, C
    Kernan, NA
    Drobyski, WR
    Giralt, S
    Flowers, MED
    Casper, J
    Leahey, A
    Parker, P
    Mick, R
    Bate-Boyle, B
    King, R
    Antin, JH
    BLOOD, 2000, 95 (04) : 1214 - 1221
  • [49] Renal transplantation and immunosuppressive therapy does not controindicate the possibility to be a stem cell donor for bone marrow transplantation.
    Amore, A
    Gaido, M
    Fagioli, F
    Saracco, P
    Coppo, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 376A - 376A
  • [50] DONOR BUFFY COAT INFUSIONS FOR A PATIENT WITH MYELODYSPLASTIC SYNDROME WHO RELAPSED FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    TSUZUKI, M
    MARUYAMA, F
    KOJIMA, H
    EZAKI, K
    HIRANO, M
    BONE MARROW TRANSPLANTATION, 1995, 16 (03) : 487 - 489
12345